← Back to all treatments
Wegovy Licensed
(semaglutide) · Once weekly injection
Wegovy (semaglutide 2.4mg) is the first GLP-1 receptor agonist specifically licensed for weight management in the UK. Backed by extensive clinical trials, it offers proven, sustained weight loss alongside cardiovascular benefits.
How It Works
Wegovy mimics the natural GLP-1 hormone, reducing hunger signals in the brain and slowing stomach emptying. This helps you feel fuller for longer and naturally eat less, making sustainable weight loss more achievable.
Key Facts
- Average Weight Loss 15–17%
- Frequency Once weekly injection
- Mechanism Licensed GLP-1 Agonist
Possible Side Effects
- Nausea (most common, usually temporary)
- Headache
- Diarrhoea or Constipation
- Abdominal pain
Eligibility
- BMI of 30 or above
- BMI of 27+ with at least one weight-related condition
- Age 18 or over
- Not pregnant or breastfeeding
Treatment Pricing
0.25 mg (Starting)£169.00
0.5 mg£189.00
1.0 mg£189.00
1.7 mg£259.00
2.4 mg (Maintenance)£309.00
